Add to ORKGBackground: Increasing evidence suggests a continuous rela-tionship between blood glucose concentrations and cardiovascular risk, even below diagnostic threshold levels for diabetes. Objective: To examine the relationship between hemoglobin A1c, cardiovascular disease, and total mortality
ObjectivesThis study was designed to examine the relationship between glycosylated hemoglobin (HbA1C...
The increased mortality reported with intensive glycaemic control has been attributed to an increase...
Chronic hyperglycemia in type 2 diabetes increases the risk of microvascular events. However, there ...
Background: Increasing evidence suggests a continuous relationship between blood glucose concentrati...
Background—Among individuals without diabetes, elevated hemoglobin A1c (HbA1c) has been associated w...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
OBJECTIVEdTo identify predictors of low hemoglobin A1c (HbA1c) (,5.0%) and to inves-tigate the assoc...
OBJECTIVE—We compared A1C and fasting plasma glucose (FPG) in predicting cardiovas-cular disease (CV...
Objective: To examine the relationship between glycated haemoglobin A1c (HbA1c) levels and the risk ...
Diabetes is a well-recognized risk factor for cardiovascular diseases. Evidence suggests a linear re...
Background-—Hemoglobin A1c (HbA1c), a time-integrated marker of glycemic control, predicts risk of c...
LettersAmong diabetic patients, hemoglobin A1c (HbA1c) is an important indicator of glycemic control...
This study explored the relationship between the glycated hemoglobin (HbA1c) level in patients with ...
ObjectivesThis study was designed to examine the relationship between glycosylated hemoglobin (HbA1C...
The increased mortality reported with intensive glycaemic control has been attributed to an increase...
Chronic hyperglycemia in type 2 diabetes increases the risk of microvascular events. However, there ...
Background: Increasing evidence suggests a continuous relationship between blood glucose concentrati...
Background—Among individuals without diabetes, elevated hemoglobin A1c (HbA1c) has been associated w...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
Background: Biomarkers may contribute to improved cardiovascular risk estimation. Glycated hemoglobi...
OBJECTIVEdTo identify predictors of low hemoglobin A1c (HbA1c) (,5.0%) and to inves-tigate the assoc...
OBJECTIVE—We compared A1C and fasting plasma glucose (FPG) in predicting cardiovas-cular disease (CV...
Objective: To examine the relationship between glycated haemoglobin A1c (HbA1c) levels and the risk ...
Diabetes is a well-recognized risk factor for cardiovascular diseases. Evidence suggests a linear re...
Background-—Hemoglobin A1c (HbA1c), a time-integrated marker of glycemic control, predicts risk of c...
LettersAmong diabetic patients, hemoglobin A1c (HbA1c) is an important indicator of glycemic control...
This study explored the relationship between the glycated hemoglobin (HbA1c) level in patients with ...
ObjectivesThis study was designed to examine the relationship between glycosylated hemoglobin (HbA1C...
The increased mortality reported with intensive glycaemic control has been attributed to an increase...
Chronic hyperglycemia in type 2 diabetes increases the risk of microvascular events. However, there ...